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3084Objective: A number of established regional quality improvement collaboratives have partnered to assess and
improve care across their regions under the umbrella of the Cardiac Surgery Quality Improvement (IMPROVE)
Network. The first effort of the IMPROVE Network has been to assess regional differences in potentially discre-
tionary transfusions (<3 units red blood cells [RBCs]).
Methods:We examined 11,200 patients undergoing isolated nonemergent coronary artery bypass graft surgery
across 56 medical centers in 4 IMPROVE Network regions between January 2008 and June 2012. Each center
submitted the most recent 200 patients who received 0, 1, or 2 units of RBC transfusion during the index admis-
sion. Patient and disease characteristics, intraoperative practices, and percentage of patients receiving RBC
transfusions were collected. Region-specific transfusion rates were calculated after adjusting for pre- and intra-
operative factors among region-specific centers.
Results: There were small but significant differences in patient case mix across regions. RBC transfusions of 1
or 2 units occurred among 25.2% of coronary artery bypass graft procedures (2826 out of 11,200). Significant
variation in the number of RBC units used existed across regions (no units, 74.8% [min-max, 70.0%-84.1%], 1
unit, 9.7% [min-max, 5.1%-11.8%], 2 units, 15.5% [min-max, 9.1%-18.2%]; P<.001). Variation in overall
transfusion rates remained after adjustment (9.1%-31.7%; P<.001).
Conclusions: Delivery of small volumes of RBC transfusions was common, yet varied across geographic regions.
These data suggest that differences in regional practice environments, including transfusion triggers and anemia
management, may contribute to variability in RBC transfusion rates. (J Thorac Cardiovasc Surg 2014;148:3084-9)See related commentary on pages 3089-91.
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The Journal of Thoracic and Cardiovascular SurFor more than 2 decades the Society of Thoracic Surgeons
(STS) (and more recently, public and private payers) has
encouraged cardiothoracic surgeons to participate in a na-
tional cardiac surgical registry designed to facilitate the
assessment of clinical practice and outcomes from these
surgical procedures. Data from this registry have been
used for research, as well as to support quality assurance
and improvement. Although contributing surgeons receive
detailed reports describing the process and outcomes of
their care, comparative outcomes reporting alone often fails
to positively transform care.
Regional voluntary collaboratives for heart surgery have
also emerged over the past several decades. Unlike a registry,
a surgical collaborative is a consortiumof institutions that dis-
cusses opportunities for working together to improve the
quality and safety of care. Within cardiac surgery, such col-
laboratives are typically state-based with the majority using
STS data elements. Many regional collaboratives have lever-
aged physician champions to convene surgeons and allied
health professionals on a regular basis to focus their energy
and intellect on a broad variety of quality improvement
initiatives. In this fashion, these groups have turned registry
data into information useful for targeted action, thus demon-
strating improvement in the process and outcomes of car-
diovascular surgical care in each of their regions.gery c December 2014
Abbreviations and Acronyms
CABG ¼ coronary artery bypass graft
IMPROVE¼ Cardiac Surgery Quality Improvement
Network
RBC ¼ red blood cell
STS ¼ Society of Thoracic Surgeons
Likosky et al Perioperative ManagementRepresentatives from several of these regional collabora-
tives recently convened to discuss opportunities to drive
quality assurance and improvement on a much larger
scale. Although each collaborative has a similar mission,
namely the improvement of cardiothoracic surgical care and
outcomes, no formal process has existed tobenchmarkperfor-
mance across these groups. The groups have agreed to share
aggregated data and expertise to further evaluate and improve
the quality, safety, and cost of cardiac surgical care both
within and across regions under the umbrella of the Cardiac
Surgery Quality Improvement (IMPROVE) Network (http://
www.improvenetwork.org).
Given prior work in and outside of collaboratives,
coupled with growing interest on the topic within the sur-
gical community, members of the IMPROVE Network
have agreed to use clinical registry data to benchmark red
blood cell (RBC) transfusion practices. In particular, the
IMPROVE Network seeks to use these data to assess
variability in rates of potentially discretionary RBC transfu-
sions. We report our findings from a prospective, obser-
vational study of patients undergoing isolated coronary
artery bypass graft (CABG) surgery across 56 medical cen-
ters in 4 IMPROVE Network regions.P
MMETHODS
Study Population
The IMPROVE Network is composed of 5 regional quality improve-
ment collaboratives: The Clinical Outcomes Assessment Program, Mari-
time Cardiovascular Quality Initiative, Michigan Society of Thoracic and
Cardiovascular Surgeons, Northern New England Cardiovascular Disease
Study Group, and Providence Health and Services Cardiovascular Disease
Study Group. The IMPROVE Network has developed a set of bylaws to
govern its work, along with a mission: ‘‘to improve the value of cardiovas-
cular surgical care by developing and sharing best practice knowledge,
coordinating, undertaking, evaluating, and disseminating quality improve-
ment projects across our member organizations.’’
We examined patients undergoing isolated, nonemergent CABG
surgery at any of 56 medical centers across 4 IMPROVE Network regions
between January 1, 2008, and June 30, 2012.
We excluded any case in which a patient was transfused 3 RBC units
during the intra- or postoperative period. After excluding patients with emer-
gent status and those missing data on gender, the final 200 isolated CABG
cases in each center were retained for analysis, leaving a final sample of
11,200 patients from 56 centers and 4 regions. Centers with<200 cases
meeting the criteria were excluded from the analysis. Due to privacy con-
cerns, only aggregate, de-identified data from each center were used.
The University ofMichigan’s institutional review board deemed that the
use of such data was not regulated (HUM00071282).The Journal of Thoracic and CarData Collection
All data were collected locally at each medical center and aggregated to
means or percentages at the region level by each collaborative using
standardized definitions.1 Information specific to preoperative care
included patient demographics (eg, age, sex, and weight), comorbid disease
(eg, diabetes, peripheral vascular disease, hypertension, dialysis, last
preoperative serum creatinine, chronic lung disease, and last preoperative
hematocrit), medications (eg, aspirin within 5 days of surgery and other
antiplatelet agents), cardiac history (eg, cardiovascular disease, heart
failure within 2 weeks of surgery, and myocardial infarction), days from
cardiac catheterization to CABG surgery, cardiac anatomy and function
(eg, left main disease, ejection fraction, and number of diseased vessels),
prior CABG surgery, and urgent status. We additionally collected
intraoperative factors, including use of off-pump procedure, crossclamp
duration, and cardiopulmonary bypass duration.
Statistical Analysis
Given that 4 medical centers participated simultaneously in 2 regional
collaboratives, each center was randomly allocated to contribute data to
only 1 collaborative for analysis.
Demographics are presented as the means of all center means within
each region. We similarly present the means within each category for
categorical variables. Comparisons between regions were made using
analysis of variance.
A logistic regression model using aggregated data from each center was
used to compute risk-adjusted rates of transfusion for each region. We
explored the effect of pre- and intraoperative factors in our modeling.
We include in the logistic regression model a class variable corresponding
to the region and pre- and intraoperative center characteristics. Pre- and
intraoperative center characteristics were chosen via backward selection
with the goal of minimizing Akaike information criterion.2 The
risk-adjusted rate for each region is calculated by fixing each pre- and
intraoperative center characteristic at the same level (ie, the overall mean
across all regions) and therefore the risk-adjusted rates are adjusted for
differences in pre- and intraoperative factors. Observed rates and
asymptotic standard errors were computed from the raw data.
For each region, these rates and their 95% confidence intervals were
plotted. Differences between risk-adjusted regional rates were further
assessed by testing for the significance of region as a fixed effect in the
adjusted model.
We conducted a sensitivity analysis specifically focused on the
contribution of the highest transfusion rate region (ie, Region 4) to our
overall findings. Specifically, we compared the adjusted transfusion rates
with and without Region 4.
Analyses were performed using R 3.0.1 (R Foundation for Statistical
Computing, Vienna, Austria) and SAS 9.3 (SAS Institute Inc, Cary, NC).
RESULTS
Comparisons of pre- and intraoperative characteristics
across the 4 regional collaboratives are displayed in
Table 1. Clinically relevant differences did not exist
exclusive of some noteworthy exceptions. Region 4 had
the highest proportion of patients with severe chronic lung
disease (4.9%). Region 2 had the highest proportion of
myocardial infarctions within 7 days (39.4%), urgent status
(73.5%), aspirin use (97.8%), and off-pump procedures
(28.1%). The use of off-pump procedures in Region 2
was predominantly driven by 1 center.
Within our cohort, 25.2% of patients (2826 out of
11,200) received transfusions of 1 or 2 units RBCs. Of
these, 9.7% received only 1 unit, whereas 15.5% receiveddiovascular Surgery c Volume 148, Number 6 3085
TABLE 1. Characteristics associated with intra- or postoperative transfusions across the 4 regional collaboratives (N ¼ 56 centers)
Variables Overall
Region
P value1 2 3 4
Preoperative factors
Age (y) 64.5 (1.3) 64.2 (2.0) 65.8 (1.0) 65 (1.3) 64.1 (1.1) .024
Male (%) 77.9  4.5 80.4  4.5 78.4  1.5 78.2  5.1 77.3  4.4 .454
Body surface area (m2) 2.1 (0.03) 2 (0.03) 2.1 (0.02) 2.1 (0.01) 2 (0.03) <.001
Cardiovascular disease 13.5 (3.2) 11.8 (2.4) 12.5 (4.8) 13.1 (3.6) 14.1 (2.9) .365
PVD 13.5 (4.3) 13.3 (5.9) 16.6 (3.8) 11.6 (3.1) 14 (4.3) .142
Chronic lung disease
Mild 14.8 (6.3) 11.3 (5.0) 12.7 (2.6) 13.7 (4.8) 16.2 (7.0) .220
Moderate 5 (3.6) 1.7 (1.3) 4.5 (5.8) 5.4 (5.4) 5.5 (2.6) .099
Severe 3.8 (3.2) 2.2 (1.8) 3.6 (1.6) 2.2 (2.2) 4.9 (3.6) .024
Diabetes 40.6 (5.0) 40 (5.3) 38.6 (5.7) 38.6 (5.4) 41.9 (4.6) .180
Dialysis 1.5 (1.4) 1.9 (0.80) 2.8 (3.8) 1.4 (0.9) 1.3 (1.1) .169
Number of diseased vessels
0 or 1 4.8 (2.7) 4.8 (2.09) 4 (3.1) 5 (3.0) 4.7 (2.7) .931
2 20.9 (5.8) 21.2 (6.8) 20.6 (5.9) 21.6 (7.4) 20.6 (5.0) .961
3 74.4 (7.3) 74 (7.8) 75.4 (4.3) 73.4 (9.6) 74.7 (6.6) .941
Ejection fraction
<40% 12 (3.8) 13.2 (4.3) 14 (1.9) 10.5 (3.3) 12.3 (4.0) .261
40%-49% 15.2 (3.9) 13.5 (3.0) 13.9 (1.9) 15.3 (3.3) 15.7 (4.4) .556
50%-59% 31.7 (7.8) 25.7 (5.8) 26.7 (6.6) 29.7 (5.6) 34.3 (8.1) .016
60% 41 (9.7) 47.7 (8.1) 45.4 (9.6) 44.5 (8.3) 37.7 (9.5) .021
Heart failure within 2 wk 11.1 (7.6) 11.8 (3.7) 10.7 (4.3) 14.9 (11.3) 9.3 (5.8) .155
Hematocrit
<36% 20.4 (5.7) 18.8 (4.8) 23.8 (4.3) 20.3 (5.0) 20.4 (6.4) .597
36%-39% 29.5 (3.7) 31.2 (3.5) 31.4 (3.8) 28.4 (3.7) 29.5 (3.8) .321
40%-42% 26 (3.8) 26.5 (4.6) 25.4 (2.7) 26 (3.9) 26.1 (3.9) .978
43% 24 (5.6) 23.6 (4.2) 19.4 (4.4) 25.3 (5.2) 24 (6.0) .320
Hypertension 86.4 (6.2) 84.8 (5.7) 88.6 (3.6) 84 (7.5) 87.5 (6.5) .252
Left main disease 50% 33.5 (5.9) 36.1 (6.4) 33.9 (5.4) 34.3 (4.7) 32.7 (6.3) .585
Myocardial infarction 50.9 (7.7) 51.1 (11.3) 61.8 (8.1) 53.6 (5.5) 48.3 (13.5) .002
Recent myocardial infarction (7 d) 25.3 (7.7) 24.6 (6.4) 39.4 (7.7) 25 (8.3) 23.9 (6.1) .001
Urgent status 59.6 (14.6) 47.1 (13.3) 73.5 (5.9) 54.4 (14.3) 62.5 (13.5) .008
Redo coronary artery bypass graft 2.2 (1.4) 3.1 (1.9) 2 (1.4) 1.9 (1.2) 2.3 (1.4) .389
Days from cardiac catheterization to surgery 12.3  6.1 10.9  5.0 15.9  10.8 12.9  5.0 11.9  6.2 .59
Medication use within 5 d
Antiplatelet agents 2.9 (7.8) 9.5 (22.0) 9.3 (6.0) 1.1 (1.0) 1.6 (3.1) .03
Aspirin 90.9 (6.8) 83.0 (9.0) 97.8 (1.0) 86.7 (6.3) 93.5 (4.4) <.001
Last serum creatinine (mg/dL) 1.1 (0.1) 1.4 (0.08) 1.1 (0.5) 1.1 (0.1) 1.1 (0.1) <.001
Intraoperative factors
Off-pump procedure 11.5 (19.0) 5.1 (8.2) 28.1 (46.3) 12.2 (21.8) 10.2 (15.5) .32
Crossclamp duration (min) 74.3  17.2 68.7  18.2 67.3  8.3 76.8  18.4 75.2  17.5 .65
Bypass duration (% min) 100.2  17.0 93.7  17.1 101.7  6.4 101.3  19.6 99.9  13.0 .80
Values are presented as n (%) or mean  standard deviation. PVD, Peripheral vascular disease.
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M2 units (Figure 1). Significant variation in use and
number of RBC units existed across regions (no units,
74.8% [min-max, 70.0%-84.1%], 1 unit, 9.7%
[min-max, 5.1%-11.8%], and 2 units, 15.5% [min-max,
9.1%-18.2%]; P< .001) (Table 2). Variation in overall
transfusion rates remained after adjusting for pre-
and intraoperative center characteristics (9.1%-31.7%;
P<.001), as depicted in Figure 2. These findings were qua-
litatively unchanged when excluding Region 4 (P ¼ .004).3086 The Journal of Thoracic and Cardiovascular SurDISCUSSION
Within our cohort, 25.2% of patients (2826 out of
11,200) received transfusions of 1 or 2 units RBC. Rates
of 1-unit transfusions as well as 2-unit transfusions varied
more than 2-fold across regions. There was a 22.6%
absolute difference (9.1%-31.7%) in rates across regions
after adjustment. These findings suggest that there is a
lack of consensus across geographic regions in use of small
volumes of RBCs.gery c December 2014
FIGURE 1. Center transfusion rates by region. Boxes represent the
interquartile range within each center; whiskers represent the minimum
and maximum center-level transfusion rate within each region.
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MAlthough in some circumstances blood transfusions are
life-preserving (eg, replacement of volume in the setting
of acute blood loss), evidence suggests that some
transfusions may be associated with harm.3 Major bleeding
is a rare phenomenon, although 1 that is associated with
increased risk of mortality.4 To address confounding by
indication, some investigators have studied the short- and
long-term influence of small units of RBCs (ie, 1-2 units),
because these are likely not given to address active
bleeding. Parallel work from several investigative teams
have found that transfusions of 1 to 2 units RBCs are asso-
ciated with a 90% increased odds of operative mortality,5
and a 16% increased hazard of long-term3 mortality after
cardiac surgery. These compelling data suggest that small
units of RBCs may have an important influence on patient
outcomes, and identifying determinants of their use is
worthy of further investigation. Although not discounting
the potential influence of larger volumes of RBCs, we
deliberately excluded patients who received RBCs (>3
units) that may have been given to address active bleeding.
Beyond acute blood loss, small units of RBC transfusions
may be given in cardiac surgery for a number of reasons,TABLE 2. Observed transfusion of 1 or 2 units red blood cells, by region
Number of units transfused Overall 1
0 74.8 84.1 (75.0-90.0)
1 9.7 5.1 (2.5-11.0)
2 15.5 10.8 (7.5-19.0)
Values are presented as mean across centers (minimum-maximum center values) within e
The Journal of Thoracic and Carincluding decreased hematocrit levels and poor oxygen
carrying capacity. Falling hematocrit levels may occur in
patients experiencing hemodilutional anemia during
cardiopulmonary bypass.6 Clinical practice guidelines
may help guide transfusion decisions.7 In its most recent
guidelines, the STS, in conjunction with the Society of
Cardiovascular Anesthesiologists and the International
Consortium for Evidence-Based Perfusion, states that
transfusions are reasonable when hematocrit is 18%
(class IIa/level C recommendation). The clinical team
must balance the benefits of treating anemia with RBCs
against the potential harm associated with anemia and the
RBC units themselves.4 For this analysis we did not have
data from each collaborative concerning hematocrit
levels before the transfusion decisions, nor the type of
prophylactic strategies that may have been undertaken to
prevent anemia, including reduction of circuit prime
volume, ultrafiltration, or the use of retrograde autologous
priming.7,8 As such, our study was unable to determine
the extent to which these and other strategies are
differentially adopted across regions, or how their use
may help explain the apparent variation in transfusion rates.
For some time researchers at the Dartmouth Atlas of
Health Care have used Medicare claims data to reveal that
the choice of treatment is invariably driven by geographi-
cally distinct styles of practice, rather than differences in
patient presentation.9 Additionally, others have found that
practice patterns may also be driven by factors at the
provider level. For instance, Salem-Schatz and colleagues10
found that a physician’s knowledge concerning clinical
indications for transfusions as well as his/her receptivity
to input from colleagues may influence the appropriateness
of transfusions. A recent survey of cardiac team members
suggests that only 20% had institutional discussions
concerning the STS blood management guidelines, whereas
only 14% had formed institutionally based working
groups.11 Jin and colleagues12 reported a prospective study
across 12 hospitals participating in the Providence Health
and Services Cardiovascular Disease Study Group, in which
they sought to disentangle physician and institutional
contributors to transfusion decisions. They found that the
variance of transfusions across institutions was more than
twice that of surgeons practicing within a facility; surgeons
contributed to 30% of the variation in transfusion practice,
whereas the institution contributed the remaining 70%.Region
2 3 4
81.1 (75.5-84.5) 80.0 (65.0-90.5) 70.0 (52.0-87.5)
9.8 (5.0-15.0) 6.8 (1.0-22.5) 11.8 (2.5-24.0)
9.1 (2.5-11.0) 13.3 (6.5-19.5) 18.2 (4.0-29.5)
ach region.
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FIGURE 2. Transfusion rates by region. Black boxes represent observed
rates of 1 to 2 units of red blood cell transfusions, whereas gray boxes
represent risk-adjusted rates. Error bars represent 95% confidence
intervals for observed and risk-adjusted rates. *Adjusted for age, sex,
body surface area, hematocrit, dialysis, creatinine, 3-vessel disease,
crossclamp duration, bypass duration, antiplatelet agents, and aspirin use.
Perioperative Management Likosky et al
P
MFrom this the authors concluded that hospitals, rather than
individual surgeons, predominantly drive transfusion
practice. Although not restricted to small volumes of
RBCs, the work by Jin and colleagues12 suggests that
hospitals have their own transfusion signature. Our finding
complements this growing body of literature by suggesting
that geographic regions themselves may have their own
transfusion signature. Within cardiac surgery, these regions
are represented by quality improvement collaboratives
whose members meet internally to discuss quality and out-
comes and define practices to drive quality improvement.
Until recently these regional collaboratives have not had a
forum to share benchmarking data with each other. Ideally,
the partnering of the collaboratives through the IMPROVE
Network will be a means for sharing benchmarking data to
drive quality improvement on a larger geographic scale.
Our finding of geographic variability in RBC transfusion
rates is supported by previous studies. Using national
STS data, Bennett-Guerrero and colleagues13 observed
geographic differences in RBC (as well as other blood
products) use at 798 institutions performing 102,470
primary isolated CABG procedures. Use was highest
(61%) in the West South Central region (ie, Oklahoma,
Louisiana, Arkansas, and Texas) of the United States,
whereas lowest (50%) in the Mountain region (ie, Arizona,
Colorado, Idaho, Montana, Nevada, New Mexico, Utah,
and Wyoming). Similarly, wide variability occurred in rates
of transfusion of RBCs and other blood products among
patients undergoing CABG surgery with cardiopulmonary3088 The Journal of Thoracic and Cardiovascular Surbypass in US hospitals. Maddux and colleagues14 used a
dataset from a perfusion services provider to document
rates of RBC transfusions across 17,252 isolated CABG
procedures conducted at 1 of any 144 institutions located
in 32 states and Puerto Rico. Those authors reported
transfusion rates of 40.8% across institutions, although
the rates varied (Midwest, 33.7%; South, 36.1%; West,
40.5%; and Northeast, 43.1%). Together, these reports
suggest that a patient’s risk of transfusion may in part
be driven by factors other than patient presentation,
including the practice patterns of the region in which they
seek care.
As is the case with any observational study, our findings
are subject to confounding at the level of the patient,
provider, medical center, and region. Although we adjusted
for many common risk factors for blood transfusions,
including preoperative hematocrit, lingering confounding
may exist, including the reasons underlying the transfusion
decision. Although we are not able to fully rule out the
influence of unmeasured confounding, we have made
efforts to address these confounding factors both in our
study design and analysis, including limiting our cohort to
patients receiving only small increments of blood
transfusions and undergoing nonemergent operations, and
performing multivariable logistic regression analyses. We
used center-level aggregate data to describe and adjust for
differences in pre- or intraoperative practices. These data
may in some circumstances not appropriately reflect
variation at the patient or center level. Last, we hypothesize
that apparent regional differences in transfusion practices
across the IMPROVE Network may in part be explained
by regional supply and demand of blood products, or
more (or less) intensive marketing efforts by agencies (eg,
American Red Cross) to limit potentially unnecessary trans-
fusion practices. Although we were unable to account for
these regional effects, we anticipate that they would have
a marginal effect, although they would drive our findings
toward null.
Our findings suggest that there is wide geographic
variability in the use of potentially discretionary RBC
transfusions. Our findings persisted even after adjusting
for known factors that may influence transfusion rates.
Further investigation is warranted to improve our
understanding of why such variability in transfusion rates
persists. Partnerships across geographic regions, including
through the IMPROVE Network, may serve as a vehicle
for undertaking and evaluating the effectiveness of such in-
vestigations, including those seeking to reduce unwarranted
variability in practice.
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MThe decision to administer a perioperative blood
transfusion involves a balance between the risks of
receiving an allogeneic donor unit and the benefits of
volume replacement and improved oxygen-carrying
capacity. Every experienced surgeon has a patient whose
life was saved by a blood transfusion. On the other hand,
an overwhelming amount of evidence suggests that
perioperative blood transfusion translates into adverse
surgical outcomes in some circumstances. In their study
published in this issue of the Journal, Likosky and
coauthors1 evaluated a subgroup of patients undergoing
elective coronary artery bypass grafting (CABG) who
received a so-called discretionary transfusion of packed
red blood cells (PRBCs). They used a subset of the Society
of Thoracic Surgeons adult cardiac surgical database from5 regional collaboratives in the Cardiac Surgery Quality
Improvement (IMPROVE) network to identify 2 groups
of patients: 1 group receiving 1 or 2 units of PRBCs and 1
with no transfusions. The study cohort was at low risk of
operative mortality, but independent of this risk there was
significant variation in the transfusion of 1 or 2 PRBC units
across regions.
Patients with low operative risk are least likely to benefit
from transfusion. For trauma patients, the association of
transfusion with all-cause mortality appears to vary
according to the predicted risk of death. Transfusion may
reduce mortality in patients at high predicted risk of death
but increase mortality in those at low risk (Figure 1).2
Similarly, we found a dose-dependent relationship
between blood transfusion and morbidity and mortality in
patients undergoing noncardiac thoracic operations.3
Further, we queried the American College of Surgeons
National Surgical Quality Improvement Program database,
which contains patients undergoing mostly general surgical
procedures, for data entered between 2010 and 2012 to
identify mortality and morbidity differences in patients
receiving blood transfusion within 72 hours of the
operative procedure and those who did not receive any
blood. We calculated the relative risk of development of
a serious complication or of operative mortality in
propensity-matched patients with equivalent risks of
receiving a blood transfusion. There was an astoundingdiovascular Surgery c Volume 148, Number 6 3089
